What is BMRN's health score?

BIOMARIN PHARMACEUTICAL INC (BMRN) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BMRN's estimated fair value?

Based on our 5-year discounted cash flow model, BIOMARIN PHARMACEUTICAL INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BMRN undervalued or overvalued?

Our model currently rates BMRN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BMRN... Refresh in a moment for the full analysis.

BIOMARIN PHARMACEUTICAL INC (BMRN)

Healthcare Inconclusive inconclusive healthy

$56.47

Updated: 2026-06-05

TradeApes Score

Financial Strength

90 Strong

Operating Trend

68 Healthy

Relative Value

20 Stressed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.